The bill, H.B. No. 1644, amends the Health and Safety Code by adding a new subsection that clarifies the legal status of testing equipment used to identify substances in Penalty Group 1-B or xylazine. Specifically, it states that the provisions of Section 481.125 do not apply to individuals who use, possess with intent to use, deliver, possess with intent to deliver, or manufacture with intent to deliver such testing equipment. This change aims to ensure that individuals involved in the legitimate use of testing equipment for these substances are not penalized under existing laws.

The bill stipulates that the changes will only apply to offenses committed on or after its effective date of September 1, 2025. Any offenses that occurred prior to this date will be governed by the law in effect at that time, ensuring that individuals are not retroactively penalized under the new provisions.

Statutes affected:
Introduced: Health and Safety Code 481.125 (Health and Safety Code 481)
House Committee Report: Health and Safety Code 481.125 (Health and Safety Code 481)
Engrossed: Health and Safety Code 481.125 (Health and Safety Code 481)